Patents over Patients: How Pharmaceutical Companies use the Patent System to Keep Drug Costs High
Richmond Journal of Law and Technology
NOVEMBER 27, 2023
10] Although the initial patent on Humira expired in 2016, thanks to the over 75 patents filed three years before its expiration, AbbVie is set to hold the monopoly until 2034. [11] 19] The lawsuit ended in a settlement with Gilead agreeing to pay Teva, the supposed infringer, $1.5 have over 100 attempted patents per drug. [8]
52 
Let's personalize your content